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doi:10.1016/j.asjsur.2012.04.022Summary Objective: We retrospectively evaluated the usefulness of sennoside as an agent
for mechanical bowel preparation prior to elective colon cancer surgery.
Methods: A total of 86 patients were given 12 mg of sennoside on the evening prior to resective
surgery for colon cancer, followed by intravenous antimicrobial prophylaxis used on the day of
surgery or until postoperative day 2.
Results: The incidence of surgical site infection in the study group was 4.7%, which was compa-
rable to that in the historical control patients (3.5%, p> 0.99), who had received polyethylene
glycol for mechanical bowel preparation prior to colon surgery. On multivariate logistic regres-
sion analysis, only body mass index (pZ 0.04) was an independent significant factor affecting
the surgical site infection. The intraoperative spillage was not influenced by the presence of
stenosis, although the amount of fecal matter was higher in the upstream colon segment
(p< 0.01) and downstream segment (pZ 0.07) in patients with a stenotic lesion occupying
more than two-thirds of the lumen (nZ 29) than in those without such severe stenosis
(nZ 57).
Conclusion: Sennoside seems to be an acceptable agent for mechanical bowel preparation
even in patients with stenosis.
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was administered intravenously. An additional dose wasSeveral recent meta-analyses1e3 have suggested that
routine use of mechanical bowel preparation prior to
elective colorectal surgery should be omitted, since
mechanical bowel preparation did not seem to reduce the
incidence of anastomotic leakage or wound infection.
Despite the results of the meta-analyses, various types of
mechanical bowel preparation, including with the use of
polyethylene glycol (PEG), the standard agent used most
frequently for mechanical bowel preparation, seem to have
been undertaken prior to colon surgery, at least until
recently, not only in Japan,4,5 but also in Western
countries.6e8 In addition, some investigators9 claimed that
different mechanical preparation methods, as compared
with no preparation, should be reconsidered in stratified
studies. The evidence derived from the meta-analyses do
not seem to be applicable to specific situations such as
laparoscopic colorectal surgery or colorectal resection
requiring intraoperative colonoscopy to identify the
lesions.
It has been reported that PEG is not tolerated well in
some patients. Discomfort was reported as an adverse
effect in 20.7% to 25% of the patients and vomiting in 2.7%
to 11% of the patients given PEG prior to colonoscopy or
elective colorectal surgery.10e13 Sennoside, an extract of
senna, is used widely as a stimulant laxative, and its safety
and efficacy have been established.14 However, little is
known about the usefulness of sennoside for mechanical
cleansing prior to elective colon surgery.
The above prompted us to evaluate the usefulness of
sennoside in terms of the incidence of surgical site infec-
tion, tolerance, and degree of colonic cleanness obtained.
We present our data and discuss the potential usefulness of
sennoside in colorectal surgery.
2. Patients and methods
2.1. Patients
The study group were 86 patients who were given sennno-
side (Pursennid, Novartis Pharma, Tokyo, Japan) for
mechanical bowel preparation prior to elective colon
cancer surgery between July 2007 and December 2008 at
our department. The patients who were not scheduled to
undergo any bowel preparation because of complete or
incomplete obstruction were excluded from the study.
Written informed consent for use of sennoside as the agent
for preoperative mechanical bowel preparation was
obtained from each patient.
2.2. Bowel preparation and intravenous antibiotic
use
All the eligible patients received 3 g of kanamycin and 2.4 g
of erythromycin administered orally in three divided doses
within 24 hours of the surgery. They were also given 12 mg
sennnoside diluted in a glass of water the evening before
the surgery (about 8e12 hours before the surgery). They did
not receive any additional bowel preparations, such asenema. After induction of anesthesia, 1 g of cefmetazole
administered if the duration of surgery exceeded 3 hours. In
addition, the patients received one additional dose of
cefmetazole 1 hour after the completion of the surgery or
four additional doses over next 2 consecutive days after the
surgery, according to the preference of the surgeons.2.3. Procedures for the prevention of surgical site
infection
Surgical wounds more than 7 cm long were covered with
surgical towels, while those of minilaparotomy ( 7 cm
long),15e18 an alternative to the usual laparoscopic
approach, were covered with a wound protector (Applied
Medical, Rancho Santa Margaria, CA, USA). Stapled anas-
tomoses were performed to achieve bowel continuity in all
patients. The abdominal cavity was washed with copious
amounts (2e3 L) of saline before the wounds were closed.
All gloves were changed after washing the abdominal
cavity. After the fascia was approximated using absorbable
sutures, the incisional site was washed with 200 mL of
saline before closure of the skin, which was accomplished
with a skin stapler. The incision site was covered with
a sterile dressing, which was removed within 48 hours.2.4. Factors evaluated
The main outcome measure was the incidence of surgical
site infections, which was recorded according to the
Centers for Disease Control and Prevention (CDC) defini-
tion.19 Remote infection was defined as infection occurring
at a site other than the surgical site, such as pneumonia,
urinary tract infection, enteritis, or blood stream (cath-
eter-related) infection. The incidences of surgical site
infection, remote infection, re-operation and length of
postoperative hospital stay were compared between the
patients given sennoside for the bowel preparation (study
group) and the historical control patients (control group,
nZ 86). The historical control patients were selected by
matching them with the study patients for the type of
surgery and duration of intravenous antimicrobial prophy-
laxis (use of cefmetazole or cefotiam on the day of surgery
or until postoperative day 2), from among patients who had
undergone mechanical cleansing with 2 L of PEG combined
with chemical preparation using kanamycin and erythro-
mycin prior to elective colon cancer surgery. The control
patients had been enrolled in a randomized clinical trial
performed between January 2003 and June 2007.20 For the
univariate and multivariate logistic regression analyses to
determine factors affecting surgical site infection, 12
nominal variables including sex, age (< 70 years vs.  70
years), BMI (< 25 kg/m2 vs.  25 kg/m2), ASA score (I/II vs.
III), location of the primary tumor (cecum/ascending/
transverse vs. descending/sigmoid), length of skin incision
(7 cm or less vs. > 7 cm), stenosis (< 2/3 normal caliber, 
2/3 normal caliber), level of lymph node dissection (D0/D1/
D2 vs. D3), duration of surgery (< 135 min,  135min),
blood loss (< 100 mL,  100 mL), duration of intravenous
antibiotic use (limited to the day of surgery vs. until
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(sennna vs. PEG) were selected.
Tolerance to bowel preparation using sennoside was
evaluated by the presence of vomiting, abdominal pain,
distention, or the need to discontinue the bowel prepara-
tion. The operating surgeon recorded the fecal matter
consistency and intraoperative spillage of the bowel
contents according to the method described by Hollender
et al.21 The fecal matter consistency was classified into four
categories: solid; soft; fluid; or none. Intraoperative spillage
was also classified into four categories: nil; minimal;
moderate; or large. The fecalmatter consistency and degree
of intraoperative soiling were compared between patients
with stenosis and those without stenosis. Stenosis was
defined as a narrowing of the lumen by more than two-thirds
of the normal caliber in the resected specimen.
2.5. Statistics
Continuous variables were expressed as medians with the
range. For the statistical analyses, a statistical software
package (Statview version 5.0, Abacus Concepts, Inc.,
Berkeley, CA, USA) running on a Windows personal
computer was used. For comparison of the nominal vari-
ables, the Fisher exact probability test was used. Applied to
a comparison of continuous variables, the ManneWhitney
U-test was used. Logistic regression analyses were used to
identify independent risk factors for the surgical site
infection. Variables with p< 0.01 determined by univariate
analysis were entered into the multivariate analysis with
stepwise selection. p values of less than 0.05 were
considered to denote statistical significance.
3. Results
3.1. Patient characteristics
The characteristics of the patients are shown in Table 1.
The median age of the patients was 70 years (range, 32e91
years). The male/ female ratio was 62/24. The median BMI
was 22.9 kg/m2 (range, 15.9e43.1 kg/m2). The patients
were classified according to the American Society of
Anesthesiologists Physical Status (ASA) classification as
class I (nZ 17), class II (nZ 51) or class III (nZ 18). The
locations of the primary tumor were the cecum (nZ 6),
ascending colon (nZ 14), transverse colon (nZ 15),
descending colon (nZ 8) or sigmoid colon (nZ 43). The
length of the abdominal incision was 7 cm or less in 51
patients (59%), and longer than 7 cm in 35 patients (41%).
Stenosis, defined as a narrowing of the lumen by more than
two-thirds as compared to the normal caliber of the bowel,
was found in 29 patients (34%). The types of surgery
included ileocecal resection (nZ 5), right (hemi) colec-
tomy (nZ 20), transverse colectomy (nZ 8), left (hemi)
colectomy (nZ 8), sigmoidectomy (nZ 35), and other
segmental colectomy (nZ 10). Combined resection of
other organ(s) was also performed in 13 patients (15%). The
median duration of surgery was 140 minutes (range; 70e440
minutes) and the median blood loss was 105 mL (range;
10e2410 mL). The level of lymph node dissection, accord-
ing to the Japanese classification of colorectal carcinoma,11was D1 (nZ 12), D2 (nZ 17) or D3 (nZ 57). The distribu-
tion of the pTNM stage in the patients was as follows: stage
0 (nZ 7), stage I (nZ 18), stage II (nZ 17), stage III
(nZ 30), and stage IV (nZ 14). The duration of intravenous
use of cefmetazole was limited to the day of surgery in 76
patients (88%) and until postoperative day 2 in 10 patients
(12%). The two groups showed no significant differences in
terms of the age, sex, BMI, ASA, location, length of incision,
stenosis, type of surgery, combined resection, duration of
surgery, blood loss, lymph node dissection pTNM stage or
duration of intravenous antibiotic use.
3.2. Tolerance
After administration of sennoside, vomiting developed in
two patients, abdominal pain in two patients, and abdom-
inal distention in two patients. Including these 6 patients,
discontinuation of bowel preparation was not necessitated
in any of the patients.
3.3. Surgical site and remote infection
In the study group, three patients developed incisional site
infection, and one patient developed organ/space infection;
however, none of the patients developed anastomotic
leakage. In the control group, three patients developed
incisional site infection, and one patient developed organ/
space infection in addition to incisional site infection.
Therefore, the overall incidence of surgical site infection
was not significantly different between the two groups (4.7%
vs. 3.5%,p> 0.99). In the study group, onepatient developed
remote infection. Therewere no complications suggestive of
enteritis caused by methicillin-resistant Staplylococcus
aureus or Clostlidium difficile. The incidence of remote
infection was also not significantly different between the
two groups (1.2% vs. 3.5%, pZ 0.62). The incidence of re-
operation was also not significantly different between the
two groups (0% vs. 1.2%, p> 0.99). The median length of
postoperative hospital stay was 2 days longer in the control
group than in the study group (p< 0.01) (Table 2).
3.4. Univariate and multivariate logistic regression
analyses
On univariate logistic regression analysis, the BMI
(pZ 0.03) and location (pZ 0.06) were selected as factors
affecting the surgical site infection. On multivariate logistic
regression analysis, only body mass index (pZ 0.04) was an
independent significant factor affecting the surgical site
infection (Table 3).
3.5. Consistency of fecal matter and degree of
intraoperative spillage
The distribution of the presence/absence of fecal matter
and of the fecal matter consistency in the study group is
shown in Table 4. In the proximal (upstream) bowel
segment, there was no fecal matter in 39 patients (45%),
the fecal matter was solid in 3 patients (3%), soft in 10
patients (12%), and fluid in 34 patients (40%); on the other
Table 1 Patient characteristics.
Study group
(Sennoside, nZ 86)
Control group
(PEG, nZ 86)
p-value
Age (years)a 70 (32-91) 67 (29-87) 0.33
Sex (male: female) 62: 24 53: 33 0.14
Body mass index (kg/m2)a 22.9 (15.9-43.1) 22.9 (15.0-32.2) 0.76
ASAb I 17 28
II 51 43
III 18 15 0.16
Location Cecum 6 6
Ascending colon 14 19
Transverse colon 15 14
Descending colon 8 7
Sigmoid colon 43 40 0.91
Length of incision 7cm or less 51 49
Longer than 7 cm 35 37 0.76
Stenosis > 2/3 normal caliber 29 28
< 2/3 normal caliber 57 58 0.87
Type of surgery Ileocecal resection 5 4
Right (hemi) colectomy 20 28
Transverse colectomy 8 7
Left hemicolectomy 8 7
Sigmoidectomy 35 30
Other segmental colectomy 10 10 0.85
Combined resection 13 10 0.5
Liver 3 4
Duodenum 1 1
Small intestine or colorectum 3 2
Urinary bladder 1 0
Others 5 3
Duration of surgery (min)a 140 (70-440) 130 (64-715) 0.13
Blood loss (ml)a 105 (10-2410) 90 (10-1920) 0.23
Lymph node dissectionc D1 12 9
D2 17 28
D3 57 49 0.16
pTNM stage Stage 0 7 14
Stage I 18 22
Stage II 17 14
Stage III 30 17
Stage IV 14 19 0.12
Duration of intravenous
antibiotic use
Limited to the day of surgery 76 69
Until PODd 2 10 17 0.14
a Median (range).
b American society of anesthesiologists physical status.
c According to Japanese classification of colorectal carcinoma.
d Postoprative day.
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no fecal matter in 39 patients (45%), the fecal matter was
solid in 1 patient (1%), soft in 11 patients (13%), and fluid in
35 patients (41%). In the proximal bowel segment, solid,
soft or fluid matter was present in a significantly higher
percentage of patients with a stenotic lesion (nZ 29) than
in the patients without a stenotic lesion (nZ 57) (76% vs.
44%, p< 0.01). Also, in the downstream bowel segment,
solid, soft or fluid matter tended to be present in a higher
percentage of patients with a stenotic lesion than in those
without a stenotic lesion (69% vs. 47%, pZ 0.07). No
intraoperative spillage of the bowel matter was observed in
72 patients (84%). Minimal (nZ 10) or moderate spillage(nZ 4) was noted in the remaining 14 patients. Large
spillage was not noted in any of the patients. The incidence
of intraoperative spillage did not differ significantly
between the patients with a stenotic lesion and those
without a stenotic lesion (21% vs. 14%, pZ 0.54).4. Discussion
The results of this study suggest that the use of sennoside as
an agent for mechanical bowel preparation prior to elective
colon cancer surgery may be acceptable in terms of the
incidence of surgical site infection, tolerance, and
Table 2 Surgical site infection and remote infection compared between the study group and the control group.
Study group (Sennoside, nZ 86) Control group (PEG, nZ 86) p value
Overall surgical site incision 4 (4.7%) 3 (3.5%) > 0.99
Incisional site infection 3 (3.5%) 3 (3.5%) > 0.99
Organ/space infection 1 (1.2%) 1 (1.2%) > 0.99
Anastomotic dehiscence 0 (0%) 0 (0%) > 0.99
Remote infection 1 (1.2%) 3 (3.5%) 0.62
Pneumonia 1 (1.2%) 1 (1.2%)
Urinary tract infection 0 (0%) 1 (1.2%)
Blood stream (catheter-related) infection 0 (0%) 1 (1.2%)
Re-operation 0 (0%) 1 (1.2%) > 0.99
Length of postoperative hospital stay 11 (7e29) 13 (6e37) < 0.01
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patients with stenosis, but free of obstruction.
Although this was not a prospective randomized study,
the overall incidence of surgical site infection in the study
group (4.7%) was identical to that in the historical control
group (3.5%) in which the mechanical cleansing had been
performed with PEG. In addition, the incidence of surgical
site infection in this series seems to be within anTable 3 Factors affecting surgical site infection by the unvaria
Factor Univar
Odds
ratio
95%
inter
Sex male 1
female 0.973 0.23
Age <70 1
>70 2.231 0.54
Body mass Index <25 kg/m2 1
>25 kg/m2 4.410 1.12
ASAa score I/II 1
III 1.143 0.22
Location right colon 1
left colon 7.353 0.89
Length of skin incision 7 cm or less 1
>7 cm 2.924 0.70
Stenosis <2/3 normal caliber 1
>2/3 normal caliber 1.000 0.24
Lymph node dissectionb D0/D1/D2 1
D3 2.273 0.45
Duration of surgeryc <135 min 1
>135 min 1.952 0.47
Blood lossd <100 ml 1
>100 ml 5.526 0.67
Duration of intravenous
antibiotic use
limited to the
day of surgery
1
until PODe 2 1.513 0.36
Mechanical cleansing Sennoside 1
PEG 0.988 0.23
a American society of anesthesiologists physical status.
b According to Japanese classification of colorectal carcinoma.
c Median duration of surgery was 135 min.
d Median blood loss was 100 ml.
e Postoperative day.acceptable limit and superior to the recently reported
incidences of surgical site infection following colon cancer
surgery in Japan, ranging from 6.3% to 13%.4,22,23
On multivariate analysis, overweight (BMI> 25.0 kg/m2)
was the only risk factor identified to be independently
associated with surgical site infection. Obesity is generally
recognized as a risk factor for the development of surgical
site infection following various types of surgeries. Since thent and multivariate regression analyses.
iant regression
analysis
Multivariate regression
analysis
confidence
val
p-value Odds
ratio
95% confidence
interval
p-value
4-4.032 0.97
0-9.223 0.27
1
5-17.285 0.03 4.409 1.095-17.753 0.04
7-5.747 0.87
1
8-58.824 0.06 7.519 0.907-62.500 0.06
7-12.048 0.14
1-4.151 >0.99
8-11.236 0.31
2-8.070 0.36
5-45.226 0.11
2-6.329 0.57
9-4.082 0.99
Table 4 Fecal matter consistency and intraoperative spillage in the study group.
Present of
stenosis (nZ 29)
Absent of
stenosis (nZ 57)
p-value
Proximal bowel segment None 7 22 (76%) 32 25 (44%) <0.01
Solid 1 2
Soft 5 5
Fluid 16 18
Distal bowel segment None 9 20 (69%) 30 27 (47%) 0.07
Solid 1 0
Soft 5 6
Fluid 14 21
Intraoperative spillage Nil 23 6 (21%) 49 8 (14%) 0.54
Minimal 4 6
Moderate 2 2
Large 0 0
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than in Western countries, we evaluate the impact of BMI
using the cut-off value of 25.0 kg/m2, which discriminates
non-overweight from overweight individuals. Our results
concur with previous reports demonstrating overweight as
a risk factor for the development of surgical site infection
following colorectal surgery.24,25 In addition, left-sided
colon surgery also tended to be a risk factor for surgical
site infection. To the best of our knowledge, there have
been no similar reports. The reasons are unclear and
further investigation is warranted. In any case, adoption of
mechanical cleansing had little impact on the risk of
development of surgical site infection.
This study also showed that the incidence of remote
infection was not significantly different between the two
groups. The incidence of re-operation was not evaluated as
there were no cases requiring re-operation in the sennno-
side group, while one patient in the historical control group
required re-operation. This is probably because the clinical
pathway for elective colon cancer surgery was introduced
in the majority of patients of the sennnoside group. There
may be a criticism that the postoperative length of hospital
stay was relatively long in both the groups. Japanese
patients usually demand longer hospital stays than recom-
mended by their surgeons, which consequently results in
longer hospitalizations than required for recovery to their
preoperative status. Moreover, patients’ family members
tend to strongly support a longer stay.
The tolerance to sennoside was considered acceptable
in this series, because discontinuation of bowel preparation
before surgery was not necessitated in any of the patients.
We have often encountered cases in clinical practice in
Japan, especially from the geriatric age group, where
mechanical bowel cleansing using 2 L of PEG needed to be
discontinued, because of the occurrence of nausea, vom-
iting, abdominal fullness, or intolerable abdominal pain.
According to the literature, the reported incidence of
discontinuation of bowel preparation among Japanese
patients in whom 2 L of PEG was used for mechanical bowel
cleansing prior to colorectal resection was 2.2% to
3.1%.26,27 To the best of our knowledge, there have been no
prospective randomized trials comparing senna (sennoside)
with PEG for mechanical bowel preparation prior to elec-
tive colorectal surgery, except for the report by Valverdeet al.12 In their study, all patients received 2 L of 5% povi-
done iodine enema twice before colorectal surgery. They
reported that senna was better tolerated in the presence of
stenosis, even though their definition of stenosis was not
documented. Radaelli et al28 compared senna with PEG as
agents for bowel preparation prior to elective colonoscopy,
and reported that senna was significantly superior to PEG in
terms of the tolerance. The results of the present study
seem to be consistent with the results of these studies
mentioned above12,28 in terms of tolerance, although we
did not compare sennoside with PEG.
It is noteworthy that the colonic cleanness was signifi-
cantly worse in the proximal bowel segment and tended to
be worse in the distal bowel segment in patients with
stenosis than in those without stenosis. The similar
tendency noted between the proximal and distal segments
in our study participants can be assumed to be a direct
reflection of sennnoside use and the degree of stenosis,
because we did not undertake any additional mechanical
bowel preparation measures, such as enema. The presence
of stenosis did not affect the rate of intraoperative
spillage. In addition, the overall incidence of surgical site
infection was limited to 4.7% and none of the patients in
this series developed anastomotic leakage. Thus, the
greater amounts of bowel matter remaining in both the
proximal and distal bowel segments could be cleaned easily
by the operating surgeon, leading to a favorable post-
operative course regardless of the presence or absence of
stenosis. Senna, as compared with PEG, has been reported
to have the advantage of keeping the residual contents of
the colon less fluid, therefore, the risk of spillage into the
operative field is lower.12
The optimal antibiotic choice, timing and route of
administration in elective colorectal surgery remain unde-
termined. Nelson et al29 suggested from their meta-analysis
that combined oral and intravenous prophylaxis would yield
favorable results, but were still uncertain about the timing
of the oral dosing. Since two meta-analyses1,29 have chal-
lenged the necessity for mechanical bowel preparation,
establishing the timing for oral dosing has become even
more problematic, especially as it is not known whether
oral antibiotics would still be effective when the colon is
not empty. Based on our previous experience and in
agreement with the guidelines of the CDC,19 we selected
Usefulness of sennoside for colon 87a short-term (< 24 hour) chemical preparation combined
with mechanical cleansing by sennoside in this study. The
intravenous antibiotic use was limited to the day of surgery
in 88% of the patients and was continued until post-
operative day 2 in the remaining 12%, in agreement with
the recommendation of the guidelines of the CDC in the
majority of cases, even though most Japanese surgeons
usually use intravenous antibiotics for 3 to 4 days after
elective colorectal surgery.
Considering that recent meta-analyses1e3 have shown
no benefits of mechanical bowel preparation in elective
conventional open colorectal surgery, the opportunity for
applying our results to clinical practice might be limited.
Nonetheless, sennoside (senna) is easy to administer and
relatively inexpensive. In addition, this study revealed
that sennoside might be acceptable as an agent for
mechanical bowel preparation prior to elective colon
cancer surgery in terms of the tolerance and incidence of
surgical site infection, even in patients with stenosis.
Thus, sennoside (senna) may be worth evaluating in
specific situations such as laparoscopic colorectal surgery
or colorectal resection requiring intraoperative colono-
scopy within the framework of a prospective randomized
study comparing sennoside (senna) and PEG or no
preparation.References
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